According to the U.S. Food and Drug Administration, a widely used diabetes drug metformin hydrochloride extended-release tablets have been recalled from the market.
This move follows the manufacturer’s discovery of unacceptably elevated levels of a cancer-causing contaminant.
Consequently, Indian pharmaceutical company Marksans Pharma has recalled the selling of the product.
Metformin tablets are used to treat type 2 diabetes and are designed to lower glucose levels.
Seven other pharmaceutical companies have issued recalls for metformin hydrochloride extended-release tablets due to their carcinogenic contents.
Nigel Bell Readers Bureau, Contributor
Edited by Jesus Chan
Do you want to add feedback to this story? Please add a comment in the e-mail box below, send an email to firstname.lastname@example.org, send us a message on WhatsApp at 646-874-7976 or Call us at 201-500-7715